OBJECTIVE: The purpose of this study was to examine the discrepancies between the clinical diagnosis of parkinsonism and neuropathological findings in a population-based cohort with parkinsonian disorders. BACKGROUND: The specific clinical diagnosis of parkinsonism is challenging, and definite confirmation requires neuropathological evaluation. Currently, autopsies are seldom performed, and most brain autopsies represent atypical or diagnostically unresolved cases. METHODS: We used a defined population-based incidence cohort with clinical parkinsonism (n = 669) from the Rochester Epidemiology Project in Olmsted County, Minnesota, 1991-2010. We reviewed reports of all patients who underwent neuropathologic examination at autopsy (n = 60; 9%) and applied consensus pathologic guidelines for neurodegenerative disease diagnosis. RESULTS: Among the 60 patients examined pathologically, the median time from the last recorded clinical diagnosis to death was 7 years (range from 2 to 17 years). Clinical-pathological concordance was found in 52 cases (86.7%), whereas 8 (13.3%) had a clinical-pathological discrepancy. Four patients with a clinical diagnosis of idiopathic Parkinson's disease had no pathological evidence of Lewy bodies or α-synucleinopathy; of these, pathological diagnoses were Alzheimer's disease (2 cases), progressive supranuclear palsy (1 case), and vascular parkinsonism (1 case). Two patients with clinical diagnoses of "dementia with Lewy bodies" and one patient with an "unspecified parkinsonism" had a pathological diagnosis of Alzheimer's disease without concomitant α-synuclein lesions. One patient with clinically diagnosed "progressive supranuclear palsy" had indeterminate pathological findings without α-synuclein or Aβ- or tau-immunoreactive lesions at autopsy. CONCLUSIONS: Overall, the clinical diagnoses of parkinsonian subtypes had good concordance with pathological confirmation (86.7%). However, clinical-pathological discrepancies were documented in 13.3%.
OBJECTIVE: The purpose of this study was to examine the discrepancies between the clinical diagnosis of parkinsonism and neuropathological findings in a population-based cohort with parkinsonian disorders. BACKGROUND: The specific clinical diagnosis of parkinsonism is challenging, and definite confirmation requires neuropathological evaluation. Currently, autopsies are seldom performed, and most brain autopsies represent atypical or diagnostically unresolved cases. METHODS: We used a defined population-based incidence cohort with clinical parkinsonism (n = 669) from the Rochester Epidemiology Project in Olmsted County, Minnesota, 1991-2010. We reviewed reports of all patients who underwent neuropathologic examination at autopsy (n = 60; 9%) and applied consensus pathologic guidelines for neurodegenerative disease diagnosis. RESULTS: Among the 60 patients examined pathologically, the median time from the last recorded clinical diagnosis to death was 7 years (range from 2 to 17 years). Clinical-pathological concordance was found in 52 cases (86.7%), whereas 8 (13.3%) had a clinical-pathological discrepancy. Four patients with a clinical diagnosis of idiopathic Parkinson's disease had no pathological evidence of Lewy bodies or α-synucleinopathy; of these, pathological diagnoses were Alzheimer's disease (2 cases), progressive supranuclear palsy (1 case), and vascular parkinsonism (1 case). Two patients with clinical diagnoses of "dementia with Lewy bodies" and one patient with an "unspecifiedparkinsonism" had a pathological diagnosis of Alzheimer's disease without concomitant α-synuclein lesions. One patient with clinically diagnosed "progressive supranuclear palsy" had indeterminate pathological findings without α-synuclein or Aβ- or tau-immunoreactive lesions at autopsy. CONCLUSIONS: Overall, the clinical diagnoses of parkinsonian subtypes had good concordance with pathological confirmation (86.7%). However, clinical-pathological discrepancies were documented in 13.3%.
Authors: Hiroshige Fujishiro; Tanis J Ferman; Bradley F Boeve; Glenn E Smith; Neill R Graff-Radford; Ryan J Uitti; Zbigniew K Wszolek; David S Knopman; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson Journal: J Neuropathol Exp Neurol Date: 2008-07 Impact factor: 3.685
Authors: David J Irwin; Murray Grossman; Daniel Weintraub; Howard I Hurtig; John E Duda; Sharon X Xie; Edward B Lee; Vivianna M Van Deerlin; Oscar L Lopez; Julia K Kofler; Peter T Nelson; Gregory A Jicha; Randy Woltjer; Joseph F Quinn; Jeffery Kaye; James B Leverenz; Debby Tsuang; Katelan Longfellow; Dora Yearout; Walter Kukull; C Dirk Keene; Thomas J Montine; Cyrus P Zabetian; John Q Trojanowski Journal: Lancet Neurol Date: 2017-01 Impact factor: 44.182
Authors: T Komori; N Arai; M Oda; H Nakayama; H Mori; S Yagishita; T Takahashi; N Amano; S Murayama; S Murakami; N Shibata; M Kobayashi; S Sasaki; M Iwata Journal: Acta Neuropathol Date: 1998-10 Impact factor: 17.088
Authors: H Shimura; N Hattori; S Kubo; M Yoshikawa; T Kitada; H Matsumine; S Asakawa; S Minoshima; Y Yamamura; N Shimizu; Y Mizuno Journal: Ann Neurol Date: 1999-05 Impact factor: 10.422
Authors: Dagmar H Hepp; Dana L E Vergoossen; Evelien Huisman; Afina W Lemstra; Henk W Berendse; Annemieke J Rozemuller; Elisabeth M J Foncke; Wilma D J van de Berg Journal: J Neuropathol Exp Neurol Date: 2016-08-11 Impact factor: 3.685
Authors: Aron S Buchman; Sue E Leurgans; Lei Yu; Robert S Wilson; Andrew S Lim; Bryan D James; Joshua M Shulman; David A Bennett Journal: Neurology Date: 2016-08-03 Impact factor: 9.910
Authors: Pierpaolo Turcano; Michelle M Mielke; James H Bower; Joseph E Parisi; Jeremy K Cutsforth-Gregory; J Eric Ahlskog; Rodolfo Savica Journal: Neurology Date: 2018-11-07 Impact factor: 9.910
Authors: Cole D Stang; Pierpaolo Turcano; Michelle M Mielke; Keith A Josephs; James H Bower; J Eric Ahlskog; Bradley F Boeve; Peter R Martin; Sudhindra G Upadhyaya; Rodolfo Savica Journal: J Parkinsons Dis Date: 2020 Impact factor: 5.568
Authors: Araceli Alonso-Canovas; Jose Luis Lopez-Sendon Moreno; Javier Buisan; Susana Sainz de la Maza; Lucienne Costa-Frossard; Guillermo Garcia-Ribas; Alicia de Felipe-Mimbrera; Maria Consuelo Matute-Lozano; Beatriz Zarza Sanz; Rafael Toledano Delgado; Iñigo Corral; Jaime Masjuan; Juan Carlos Martinez-Castrillo Journal: J Neurol Date: 2018-08-16 Impact factor: 4.849
Authors: Cole D Stang; Aidan F Mullan; Emanuele Camerucci; Mania Hajeb; Pierpaolo Turcano; Peter Martin; Michelle M Mielke; Keith A Josephs; Matthew Splett; Victor Abler; Bradley F Boeve; James H Bower; Rodolfo Savica Journal: J Parkinsons Dis Date: 2022 Impact factor: 5.520
Authors: Pierpaolo Turcano; Cole D Stang; James H Bower; J Eric Ahlskog; Bradley F Boeve; Michelle M Mielke; Rodolfo Savica Journal: Neurol Clin Pract Date: 2020-04
Authors: Mariana L Laporta; S Chandralekha Kruthiventi; Cole D Stang; Emanuele Camerucci; David P Martin; Toby N Weingarten; Andrew C Hanson; Darrell R Schroeder; David O Warner; Rodolfo Savica; Juraj Sprung Journal: Parkinsonism Relat Disord Date: 2021-06-08 Impact factor: 4.402
Authors: Cole D Stang; Aidan F Mullan; Mania Hajeb; Emanuele Camerucci; Pierpaolo Turcano; Peter Martin; Michelle M Mielke; Keith A Josephs; James H Bower; Erik K St Louis; Bradley F Boeve; Rodolfo Savica Journal: Ann Neurol Date: 2020-11-20 Impact factor: 11.274
Authors: C Marras; J C Beck; J H Bower; E Roberts; B Ritz; G W Ross; R D Abbott; R Savica; S K Van Den Eeden; A W Willis; C M Tanner Journal: NPJ Parkinsons Dis Date: 2018-07-10